These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15991803)

  • 1. Fatty acid oxidation defects as a cause of neuromyopathic disease in infants and adults.
    Olpin SE
    Clin Lab; 2005; 51(5-6):289-306. PubMed ID: 15991803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnitine deficiency disorders in children.
    Stanley CA
    Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of impaired ketogenesis in fatty acid oxidation disorders.
    Olpin SE
    Prostaglandins Leukot Essent Fatty Acids; 2004 Mar; 70(3):293-308. PubMed ID: 14769488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability.
    Olpin SE
    J Inherit Metab Dis; 2013 Jul; 36(4):645-58. PubMed ID: 23674167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial fatty-acid oxidation disorders.
    Kompare M; Rizzo WB
    Semin Pediatr Neurol; 2008 Sep; 15(3):140-9. PubMed ID: 18708005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy.
    Tein I
    J Child Neurol; 2002 Dec; 17 Suppl 3():3S57-82; discussion 3S82-3. PubMed ID: 12597056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects.
    Fuda F; Narayan SB; Squires RH; Bennett MJ
    Clin Chim Acta; 2006 May; 367(1-2):185-8. PubMed ID: 16414039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects.
    Rubio-Gozalbo ME; Bakker JA; Waterham HR; Wanders RJ
    Mol Aspects Med; 2004; 25(5-6):521-32. PubMed ID: 15363639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic approach and treatment of inherited mitochondrial fatty acid oxidation disorders].
    Peña Quintana L; Sanjurjo Crespo P
    An Esp Pediatr; 2001 Dec; 55(6):524-34. PubMed ID: 11730586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defects in mitochondrial fatty acid oxidation: clinical presentations and their role in sudden infant death.
    Pollitt RJ
    Padiatr Padol; 1993; 28(1):13-7. PubMed ID: 8446423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects in long chain fatty acid oxidation presenting as severe cardiomyopathy and cardiogenic shock in infancy.
    Dereddy NR; Kronn D; Krishnan U
    Cardiol Young; 2009 Sep; 19(5):540-2. PubMed ID: 19691901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary soya protein intake and exercise training have an additive effect on skeletal muscle fatty acid oxidation enzyme activities and mRNA levels in rats.
    Morifuji M; Sanbongi C; Sugiura K
    Br J Nutr; 2006 Sep; 96(3):469-75. PubMed ID: 16925851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mitochondrial beta-oxidation defects].
    Woldseth B; Rootwelt T
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):756-9. PubMed ID: 16541168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion.
    Ussher JR; Lopaschuk GD
    Basic Res Cardiol; 2009 Mar; 104(2):203-10. PubMed ID: 19242641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trifunctional enzyme deficiency: adult presentation of a usually fatal beta-oxidation defect.
    Schaefer J; Jackson S; Dick DJ; Turnbull DM
    Ann Neurol; 1996 Oct; 40(4):597-602. PubMed ID: 8871579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of fatty acid oxidation in chicken (Gallus gallus): interactions between genotype and diet composition.
    Collin A; Swennen Q; Skiba-Cassy S; Buyse J; Chartrin P; Le Bihan-Duval E; Crochet S; Duclos MJ; Joubert R; Decuypere E; Tesseraud S
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Jun; 153(2):171-7. PubMed ID: 19258045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
    Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
    Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.
    Laforêt P; Acquaviva-Bourdain C; Rigal O; Brivet M; Penisson-Besnier I; Chabrol B; Chaigne D; Boespflug-Tanguy O; Laroche C; Bedat-Millet AL; Behin A; Delevaux I; Lombès A; Andresen BS; Eymard B; Vianey-Saban C
    Neuromuscul Disord; 2009 May; 19(5):324-9. PubMed ID: 19327992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.